Bausch Health Reports Promising R&D Trial Updates on Amiseli

LAVAL, QC / ACCESSWIRE / June 14, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global diversified pharmaceutical company enriching lives through a relentless drive to deliver better health outcomes, recently presented at two global healthcare conferences. Bausch Health's gastroenterology (GI) business,...

Related Keywords

Washington , United States , Italy , New Jersey , Milan , Lombardia , Steven Hanauer , Pabout Amiselimod , Kevin Wiggins , Clifford Joseph Barborka , Garen Sarafian , Twitter , International Liver Congress , Bausch Health , University Of Alberta , Salix Pharmaceuticals , Pharmacological Research , Bausch Health Companies Inc , Linkedin , Professor Of Medicine At Northwestern University , Bausch Health Companies , Digestive Disease Week , Annual Meeting , European Association , Modified Mayo Score , Health Companies ,